Weight-loss shot may reduce obesity, overweight

Written by Katharine Lang on February 25, 2022 — Fact checked by Anna Guildford, Ph.D.

• Obesity and overweight are widespread globally and increase the risk of many health conditions.
• A new injectable treatment, semaglutide, has just been recommended for use in the United Kingdom.
• In a study, those on the treatment lost, on average, almost 15% of their body mass.
• The injections could help those who wish to achieve a moderate weight.

The World Health Organization (WHO) defines overweight and obesity as: “abnormal or excessive fat accumulation that may impair health.”

Worldwide, obesity rates have almost tripled since 1975, and they are still increasing. In 2018, the Centers for Disease Control and Prevention (CDC) defined obesity as a BMI of 30 or higher and stated that 42.4% of adults in the United States had obesity. In 2019, 27% of males and 29% of females in the U.K. had obesity.

Read the entire article HERE.